Potential of E-Learning Interventions and Artificial Intelligence-Assisted Contouring Skills in Radiotherapy: The ELAISA Study.

Journal: JCO global oncology
Published Date:

Abstract

PURPOSE: Most research on artificial intelligence-based auto-contouring as template (AI-assisted contouring) for organs-at-risk (OARs) stem from high-income countries. The effect and safety are, however, likely to depend on local factors. This study aimed to investigate the effects of AI-assisted contouring and teaching on contouring time and contour quality among radiation oncologists (ROs) working in low- and middle-income countries (LMICs).

Authors

  • Mathis Ersted Rasmussen
    Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Kamal Akbarov
    International Atomic Energy Agency, Vienna, Austria.
  • Egor Titovich
    International Atomic Energy Agency, Vienna, Austria.
  • Jasper Albertus Nijkamp
    Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Wouter van Elmpt
    Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands. Electronic address: wouter.vanelmpt@maastro.nl.
  • Hanne Primdahl
    Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Pernille Lassen
    Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Jon Cacicedo
    Department of Radiation Oncology, Cruces University Hospital/BioCruces Health Research Institute, Osakidetza, Barakaldo, Spain.
  • Lisbeth Cordero-Mendez
    International Atomic Energy Agency, Vienna, Austria.
  • A F M Kamal Uddin
    Labaid Cancer Hospital and Super Speciality Centre, Dhaka, Bangladesh.
  • Ahmed Mohamed
    National Cancer Institute, University of Gezira, Wad Madani, Sudan.
  • Ben Prajogi
    Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
  • Kartika Erida Brohet
    Dharmais Cancer Hospital, Jakarta, Indonesia.
  • Catherine Nyongesa
    Kenyatta National Hospital, Nairobi, Kenya.
  • Darejan Lomidze
    Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi, Georgia.
  • Gisupnikha Prasiko
    Nepal Cancer Hospital and Research Center, Lalitpur, Nepal.
  • Gustavo Ferraris
    Centro de Radioterapiya dean Funes, Cordoba, Argentina.
  • Humera Mahmood
    Atomic Energy Cancer Hospital NORI, Islamabad, Pakistan.
  • Igor Stojkovski
    University Clinic of Radiotherapy and Oncology, Skopje, Macedonia.
  • Isa Isayev
    National Center of Oncology, Baku, Azerbaijan.
  • Issa Mohamad
    King Hussein Cancer Center, Amman, Jordan.
  • Leivon Shirley
    Christian Institute of Health Science and Research, Dimapur, India.
  • Lotfi Kochbati
    Hospital Abderrahmen Mami, Ariana, Tunesia.
  • Ludmila Eftodiev
    Moldavian Oncology Institute, Chisinau, Moldova.
  • Maksim Piatkevich
    N. N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus.
  • Maria Matilde Bonilla Jara
    Hospital México, San José, Costa Rica.
  • Orges Spahiu
    Mother Tereza Hospital, Tirana, Albania.
  • Rakhat Aralbayev
    National Centre of Oncology and Hematology, Bishkek, Kyrgyzstan.
  • Raushan Zakirova
    Center of Nuclear Medicine and Oncology, Semey, Kazakhstan.
  • Sandya Subramaniam
    Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
  • Solomon Kibudde
    Uganda Cancer Institute, Kampala, Uganda.
  • Uranchimeg Tsegmed
    National Cancer Center of Mongolia, Ulaanbaatar, Mongolia.
  • Stine Sofia Korreman
    Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Jesper Grau Eriksen
    Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.